Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-12

AUTHORS

Roger Valdivieso, Katharina Boehm, Malek Meskawi, Alessandro Larcher, Zhe Tian, Marie-Elise Parent, Philip Wong, Markus Graefen, Francesco Montorsi, Maxine Sun, Fred Saad, Pierre I. Karakiewicz

ABSTRACT

BACKGROUND: Brachytherapy (BT) is a widely used treatment modality for elderly patients with localized prostate cancer (PCa). OBJECTIVE: To describe the patterns of BT use in octo- and nonagenarians treated for localized PCa in the USA. We hypothesized that most individuals treated with BT should remain alive for at least 10 years. We also postulated that BT should ideally be administered as monotherapy. PATIENTS AND METHODS: Using the Surveillance Epidemiology and End Results (SEER)-Medicare-linked database, 2701 octo- and nonagenarians treated with BT between 1992 and 2009 were identified. Cumulative incidence rates and smoothed cumulative incidence plots were used. RESULTS: In patients with low-risk characteristics, 40 % received BT alone; 27 % received BT combined with ADT; 19 % received BT and EBRT; and 14 % received BT combined with both ADT and EBRT. Of intermediate-to-high-risk patients, 19 % received BT alone; 16 % received BT combined with ADT; 19 % received BT combined with EBRT; and 45 % received BT together with ADT and EBRT. Overall survival rate was 79 and 47 % at 5 and 10 years. CONCLUSIONS: Less than half of elderly treated with BT remain alive at 10 years of follow-up. Moreover, the vast majority of those individuals not only receives BT, but is also exposed to two or even three combined therapy modalities. These findings are worrisome. More... »

PAGES

1985-1991

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00345-015-1553-0

DOI

http://dx.doi.org/10.1007/s00345-015-1553-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007992405

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25854524


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brachytherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "SEER Program", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Socioeconomic Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada", 
            "Department of Urology, University of Montreal Health Center, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valdivieso", 
        "givenName": "Roger", 
        "id": "sg:person.01166651364.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166651364.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Cancer Center Hamburg", 
          "id": "https://www.grid.ac/institutes/grid.412315.0", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada", 
            "Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boehm", 
        "givenName": "Katharina", 
        "id": "sg:person.01014067552.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014067552.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada", 
            "Department of Urology, University of Montreal Health Center, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meskawi", 
        "givenName": "Malek", 
        "id": "sg:person.01156512043.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156512043.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada", 
            "Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larcher", 
        "givenName": "Alessandro", 
        "id": "sg:person.01010102405.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010102405.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tian", 
        "givenName": "Zhe", 
        "id": "sg:person.01164150446.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164150446.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al", 
          "id": "https://www.grid.ac/institutes/grid.410559.c", 
          "name": [
            "INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, QC, Canada", 
            "University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parent", 
        "givenName": "Marie-Elise", 
        "id": "sg:person.01260315672.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260315672.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Department of Radiation Oncology, University of Montreal Health Center, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wong", 
        "givenName": "Philip", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Cancer Center Hamburg", 
          "id": "https://www.grid.ac/institutes/grid.412315.0", 
          "name": [
            "Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Graefen", 
        "givenName": "Markus", 
        "id": "sg:person.0643104745.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643104745.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montorsi", 
        "givenName": "Francesco", 
        "id": "sg:person.01320375645.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320375645.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sun", 
        "givenName": "Maxine", 
        "id": "sg:person.01322416734.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322416734.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Department of Urology, University of Montreal Health Center, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saad", 
        "givenName": "Fred", 
        "id": "sg:person.01123410561.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123410561.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Montreal", 
          "id": "https://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada", 
            "Department of Urology, University of Montreal Health Center, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karakiewicz", 
        "givenName": "Pierre I.", 
        "id": "sg:person.0717124312.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717124312.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.eururo.2014.08.061", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013975018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)70018-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015747100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/93.23.1822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017310274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0895-4356(00)00256-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022482018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25969", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022875977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.21208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041182772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(05)67915-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044658082"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.juro.2007.03.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045443414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005650-200208001-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052576224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005650-200208001-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052576224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(17)32403-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082571302"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: Brachytherapy (BT) is a widely used treatment modality for elderly patients with localized prostate cancer (PCa).\nOBJECTIVE: To describe the patterns of BT use in octo- and nonagenarians treated for localized PCa in the USA. We hypothesized that most individuals treated with BT should remain alive for at least 10 years. We also postulated that BT should ideally be administered as monotherapy.\nPATIENTS AND METHODS: Using the Surveillance Epidemiology and End Results (SEER)-Medicare-linked database, 2701 octo- and nonagenarians treated with BT between 1992 and 2009 were identified. Cumulative incidence rates and smoothed cumulative incidence plots were used.\nRESULTS: In patients with low-risk characteristics, 40 % received BT alone; 27 % received BT combined with ADT; 19 % received BT and EBRT; and 14 % received BT combined with both ADT and EBRT. Of intermediate-to-high-risk patients, 19 % received BT alone; 16 % received BT combined with ADT; 19 % received BT combined with EBRT; and 45 % received BT together with ADT and EBRT. Overall survival rate was 79 and 47 % at 5 and 10 years.\nCONCLUSIONS: Less than half of elderly treated with BT remain alive at 10 years of follow-up. Moreover, the vast majority of those individuals not only receives BT, but is also exposed to two or even three combined therapy modalities. These findings are worrisome.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00345-015-1553-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094127", 
        "issn": [
          "0724-4983", 
          "1433-8726"
        ], 
        "name": "World Journal of Urology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "name": "Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians", 
    "pagination": "1985-1991", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "26138bf8a91906ba698e448939a771686390a314b320ed3255cab44e259569a2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25854524"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8307716"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00345-015-1553-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007992405"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00345-015-1553-0", 
      "https://app.dimensions.ai/details/publication/pub.1007992405"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00345-015-1553-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00345-015-1553-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00345-015-1553-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00345-015-1553-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00345-015-1553-0'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      53 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00345-015-1553-0 schema:about N3ae2519151b541ca8db9c9cb2d6ace92
2 N3b83496150134777bd19746e7423cced
3 N3d0ef15b42944d47aaa8871649cab698
4 N57c792e50aef4a6192202d5a8eff85b2
5 N6a60d57a6e6e4c35a82cc83f680e46c2
6 N6de4e4f856844417849ad5901e4bf7d4
7 N8be87d3943c04026a2160259d731c48f
8 N8ec5e6b0266e467f87dc5342250a8ea3
9 Nacdc09222cc54de5a7690f1568dbf1da
10 Ndb728e24af104d3592c7c58e079b2e65
11 Ndfd2cd2400e641109b1a09700aeeccc0
12 Nf3a2bc2954d949c0b44c276bbcc86ac9
13 Nf95df87eb167417fbf0a02ea6d01446f
14 Nfbbb822db4d744ea954e57dce86ef43d
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N5e2a489774644189b387daa656ed90d3
18 schema:citation https://doi.org/10.1002/cncr.25969
19 https://doi.org/10.1016/j.eururo.2014.08.061
20 https://doi.org/10.1016/j.juro.2007.03.003
21 https://doi.org/10.1016/s0022-5347(05)67915-3
22 https://doi.org/10.1016/s0022-5347(17)32403-5
23 https://doi.org/10.1016/s0895-4356(00)00256-0
24 https://doi.org/10.1016/s1470-2045(14)70018-x
25 https://doi.org/10.1093/jnci/93.23.1822
26 https://doi.org/10.1097/00005650-200208001-00002
27 https://doi.org/10.3322/caac.21208
28 schema:datePublished 2015-12
29 schema:datePublishedReg 2015-12-01
30 schema:description BACKGROUND: Brachytherapy (BT) is a widely used treatment modality for elderly patients with localized prostate cancer (PCa). OBJECTIVE: To describe the patterns of BT use in octo- and nonagenarians treated for localized PCa in the USA. We hypothesized that most individuals treated with BT should remain alive for at least 10 years. We also postulated that BT should ideally be administered as monotherapy. PATIENTS AND METHODS: Using the Surveillance Epidemiology and End Results (SEER)-Medicare-linked database, 2701 octo- and nonagenarians treated with BT between 1992 and 2009 were identified. Cumulative incidence rates and smoothed cumulative incidence plots were used. RESULTS: In patients with low-risk characteristics, 40 % received BT alone; 27 % received BT combined with ADT; 19 % received BT and EBRT; and 14 % received BT combined with both ADT and EBRT. Of intermediate-to-high-risk patients, 19 % received BT alone; 16 % received BT combined with ADT; 19 % received BT combined with EBRT; and 45 % received BT together with ADT and EBRT. Overall survival rate was 79 and 47 % at 5 and 10 years. CONCLUSIONS: Less than half of elderly treated with BT remain alive at 10 years of follow-up. Moreover, the vast majority of those individuals not only receives BT, but is also exposed to two or even three combined therapy modalities. These findings are worrisome.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N0135a969fd2541edb21476ab06d8f500
35 N8f920f6608314726b790dedbdd36bdd2
36 sg:journal.1094127
37 schema:name Patterns of use and patient characteristics: brachytherapy for localized prostate cancer in octo- and nonagenarians
38 schema:pagination 1985-1991
39 schema:productId Na57c81ba8f62496c810225b36bc19066
40 Nb4f562cad45f464d84b601a9f06e48e6
41 Nc6dbdef85d7b4669aad4d20052458ba4
42 Nfc96b38acdc7449b8296e9eb7eef82e9
43 Nfd74eec541994a938e7636bc6a240ea9
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007992405
45 https://doi.org/10.1007/s00345-015-1553-0
46 schema:sdDatePublished 2019-04-10T18:20
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher Nf4fb7ed67e094a8e9bb479dd6c60e332
49 schema:url http://link.springer.com/10.1007%2Fs00345-015-1553-0
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N0135a969fd2541edb21476ab06d8f500 schema:volumeNumber 33
54 rdf:type schema:PublicationVolume
55 N114a6d5ebbb24b95ad7a6d749ce6dcfe rdf:first sg:person.01260315672.25
56 rdf:rest Nc4a7f1b88b3b434e955abe5cc623a3b8
57 N147a2a800c674bc09aaedc815a233efb schema:name Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
58 rdf:type schema:Organization
59 N16877d93134e4fe29495db744d3c4148 rdf:first sg:person.01156512043.22
60 rdf:rest N76057d3c61be4e059bd404db9e2441bf
61 N3ae2519151b541ca8db9c9cb2d6ace92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name SEER Program
63 rdf:type schema:DefinedTerm
64 N3b83496150134777bd19746e7423cced schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Treatment Outcome
66 rdf:type schema:DefinedTerm
67 N3d0ef15b42944d47aaa8871649cab698 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name United States
69 rdf:type schema:DefinedTerm
70 N57c792e50aef4a6192202d5a8eff85b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Brachytherapy
72 rdf:type schema:DefinedTerm
73 N5a1f03aea3914f91a7932b64f47dc251 rdf:first sg:person.01014067552.84
74 rdf:rest N16877d93134e4fe29495db744d3c4148
75 N5e2a489774644189b387daa656ed90d3 rdf:first sg:person.01166651364.81
76 rdf:rest N5a1f03aea3914f91a7932b64f47dc251
77 N63ec94f113934ffdadf3e5628d476a7a rdf:first sg:person.0643104745.70
78 rdf:rest Nd55934de5c1a4e418ce0c00c379d69d8
79 N686c058530fb4744acfa915bd630e21d rdf:first sg:person.01123410561.52
80 rdf:rest N7e4ebf76fe04418685adf0f6d9e1aadc
81 N6a60d57a6e6e4c35a82cc83f680e46c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Combined Modality Therapy
83 rdf:type schema:DefinedTerm
84 N6de4e4f856844417849ad5901e4bf7d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Patient Selection
86 rdf:type schema:DefinedTerm
87 N76057d3c61be4e059bd404db9e2441bf rdf:first sg:person.01010102405.46
88 rdf:rest Na4b92665322542a7bf36ab636a9cdf3f
89 N7e4ebf76fe04418685adf0f6d9e1aadc rdf:first sg:person.0717124312.21
90 rdf:rest rdf:nil
91 N8be87d3943c04026a2160259d731c48f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Prostatic Neoplasms
93 rdf:type schema:DefinedTerm
94 N8ec5e6b0266e467f87dc5342250a8ea3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Survival Rate
96 rdf:type schema:DefinedTerm
97 N8f920f6608314726b790dedbdd36bdd2 schema:issueNumber 12
98 rdf:type schema:PublicationIssue
99 N9efaa38816454171800b7868832f0ba1 rdf:first sg:person.01322416734.99
100 rdf:rest N686c058530fb4744acfa915bd630e21d
101 Na4b92665322542a7bf36ab636a9cdf3f rdf:first sg:person.01164150446.41
102 rdf:rest N114a6d5ebbb24b95ad7a6d749ce6dcfe
103 Na57c81ba8f62496c810225b36bc19066 schema:name pubmed_id
104 schema:value 25854524
105 rdf:type schema:PropertyValue
106 Nacdc09222cc54de5a7690f1568dbf1da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Retrospective Studies
108 rdf:type schema:DefinedTerm
109 Nb4f562cad45f464d84b601a9f06e48e6 schema:name doi
110 schema:value 10.1007/s00345-015-1553-0
111 rdf:type schema:PropertyValue
112 Nc4a7f1b88b3b434e955abe5cc623a3b8 rdf:first Ncd05b042e58041189f52bf2ca1956f37
113 rdf:rest N63ec94f113934ffdadf3e5628d476a7a
114 Nc6dbdef85d7b4669aad4d20052458ba4 schema:name nlm_unique_id
115 schema:value 8307716
116 rdf:type schema:PropertyValue
117 Ncd05b042e58041189f52bf2ca1956f37 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
118 schema:familyName Wong
119 schema:givenName Philip
120 rdf:type schema:Person
121 Nd55934de5c1a4e418ce0c00c379d69d8 rdf:first sg:person.01320375645.81
122 rdf:rest N9efaa38816454171800b7868832f0ba1
123 Ndb728e24af104d3592c7c58e079b2e65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Socioeconomic Factors
125 rdf:type schema:DefinedTerm
126 Ndfd2cd2400e641109b1a09700aeeccc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Age Factors
128 rdf:type schema:DefinedTerm
129 Nf3a2bc2954d949c0b44c276bbcc86ac9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Aged, 80 and over
131 rdf:type schema:DefinedTerm
132 Nf4fb7ed67e094a8e9bb479dd6c60e332 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 Nf95df87eb167417fbf0a02ea6d01446f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 Nfbbb822db4d744ea954e57dce86ef43d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Male
139 rdf:type schema:DefinedTerm
140 Nfc96b38acdc7449b8296e9eb7eef82e9 schema:name dimensions_id
141 schema:value pub.1007992405
142 rdf:type schema:PropertyValue
143 Nfd74eec541994a938e7636bc6a240ea9 schema:name readcube_id
144 schema:value 26138bf8a91906ba698e448939a771686390a314b320ed3255cab44e259569a2
145 rdf:type schema:PropertyValue
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
150 schema:name Oncology and Carcinogenesis
151 rdf:type schema:DefinedTerm
152 sg:journal.1094127 schema:issn 0724-4983
153 1433-8726
154 schema:name World Journal of Urology
155 rdf:type schema:Periodical
156 sg:person.01010102405.46 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
157 schema:familyName Larcher
158 schema:givenName Alessandro
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010102405.46
160 rdf:type schema:Person
161 sg:person.01014067552.84 schema:affiliation https://www.grid.ac/institutes/grid.412315.0
162 schema:familyName Boehm
163 schema:givenName Katharina
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014067552.84
165 rdf:type schema:Person
166 sg:person.01123410561.52 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
167 schema:familyName Saad
168 schema:givenName Fred
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123410561.52
170 rdf:type schema:Person
171 sg:person.01156512043.22 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
172 schema:familyName Meskawi
173 schema:givenName Malek
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156512043.22
175 rdf:type schema:Person
176 sg:person.01164150446.41 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
177 schema:familyName Tian
178 schema:givenName Zhe
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164150446.41
180 rdf:type schema:Person
181 sg:person.01166651364.81 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
182 schema:familyName Valdivieso
183 schema:givenName Roger
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166651364.81
185 rdf:type schema:Person
186 sg:person.01260315672.25 schema:affiliation https://www.grid.ac/institutes/grid.410559.c
187 schema:familyName Parent
188 schema:givenName Marie-Elise
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260315672.25
190 rdf:type schema:Person
191 sg:person.01320375645.81 schema:affiliation N147a2a800c674bc09aaedc815a233efb
192 schema:familyName Montorsi
193 schema:givenName Francesco
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320375645.81
195 rdf:type schema:Person
196 sg:person.01322416734.99 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
197 schema:familyName Sun
198 schema:givenName Maxine
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322416734.99
200 rdf:type schema:Person
201 sg:person.0643104745.70 schema:affiliation https://www.grid.ac/institutes/grid.412315.0
202 schema:familyName Graefen
203 schema:givenName Markus
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643104745.70
205 rdf:type schema:Person
206 sg:person.0717124312.21 schema:affiliation https://www.grid.ac/institutes/grid.14848.31
207 schema:familyName Karakiewicz
208 schema:givenName Pierre I.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717124312.21
210 rdf:type schema:Person
211 https://doi.org/10.1002/cncr.25969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022875977
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/j.eururo.2014.08.061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013975018
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.juro.2007.03.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045443414
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/s0022-5347(05)67915-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044658082
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/s0022-5347(17)32403-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082571302
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/s0895-4356(00)00256-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022482018
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/s1470-2045(14)70018-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1015747100
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1093/jnci/93.23.1822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017310274
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1097/00005650-200208001-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052576224
228 rdf:type schema:CreativeWork
229 https://doi.org/10.3322/caac.21208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041182772
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.14848.31 schema:alternateName University of Montreal
232 schema:name Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada
233 Department of Radiation Oncology, University of Montreal Health Center, Montreal, QC, Canada
234 Department of Urology, University of Montreal Health Center, Montreal, QC, Canada
235 Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.410559.c schema:alternateName Centre Hospitalier de l’Université de Montréal
238 schema:name INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, QC, Canada
239 University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada
240 rdf:type schema:Organization
241 https://www.grid.ac/institutes/grid.412315.0 schema:alternateName University Cancer Center Hamburg
242 schema:name Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, 264 Blvd. Rene-Levesque E. Room 228, H2X 1P1, Montreal, QC, Canada
243 Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...